January 2019 FDA Recall Drug by Lupin Pharmaceuticals Inc.
D-0429-2019 - Failed Impurities/Degradation Specifications

This Class III drug recall was voluntarily initiated by Lupin Pharmaceuticals Inc. on January 28, 2019 for the product Drug. The FDA reported the reason for recall as failed impurities/degradation specifications. The product was distributed Nationwide and the recall is currently terminated.

Recall Number: D-0429-2019

Reason for Recall
Failed Impurities/Degradation Specifications: OOS results observed in any other individual impurity and total impurities.
Initiated
01-28-2019
Reported
02-13-2019
Quantity
9,930 bottles

Recall Profile & Regulatory Data

Class III - is a situation in which use of, or exposure to, a violative product is not likely to cause adverse health consequences.
Lupin Pharmaceuticals Inc.
Nationwide within the United States.
Bimatoprost Ophthalmic Solution 0.03%, packaged in a) 5 mL (NDC 68180-429-02) and b) 7.5 mL (NDC 68180-429-03) bottles, Rx only, Manufactured by: Lupin Limited Pithampur (M.P.) 454 775, INDIA.

Batch or Lot Expiration Information

Lot# a) H804506 Exp. 06/2020; 803555 Exp. 04/2020; H805394, Exp. 08/2020 b) H804112 Exp. 05/2020; H803220 Exp. 03/2020